Dissociation of glucocerebrosidase dimer in solution by its co-factor, saposin C
- National Inst. of Health (NIH), Bethesda, MD (United States)
Mutations in the gene for the lysosomal enzyme glucocerebrosidase (GCase) cause Gaucher disease and are the most common risk factor for Parkinson disease (PD). Analytical ultracentrifugation of 8 μM GCase shows equilibrium between monomer and dimer forms. However, in the presence of its co-factor saposin C (Sap C), only monomer GCase is seen. Isothermal calorimetry confirms that Sap C associates with GCase in solution in a 1:1 complex (Kd = 2.1 ± 1.1 μM). Saturation cross-transfer NMR determined that the region of Sap C contacting GCase includes residues 63–66 and 74–76, which is distinct from the region known to enhance GCase activity. Because α-synuclein (α-syn), a protein closely associated with PD etiology, competes with Sap C for GCase binding, its interaction with GCase was also measured by ultracentrifugation and saturation cross-transfer. Unlike Sap C, binding of α-syn to GCase does not affect multimerization. However, adding α-syn reduces saturation cross-transfer from Sap C to GCase, confirming displacement. To explore where Sap C might disrupt multimeric GCase, GCase x-ray structures were analyzed using the program PISA, which predicted stable dimer and tetramer forms. In conclusion, for the most frequently predicted multimer interface, the GCase active sites are partially buried, suggesting that Sap C might disrupt the multimer by binding near the active site.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- USDOE; National Institutes of Health (NIH)
- Grant/Contract Number:
- W-31-109-ENG-38
- OSTI ID:
- 1225745
- Alternate ID(s):
- OSTI ID: 1233917
- Journal Information:
- Biochemical and Biophysical Research Communications, Vol. 457, Issue 4; ISSN 0006-291X
- Publisher:
- ElsevierCopyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Web of Science
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
|
journal | February 2017 |
Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance
|
journal | February 2016 |
Did α-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson’s Disease
|
journal | July 2015 |
Distinguishing the differences in β-glycosylceramidase folds, dynamics, and actions informs therapeutic uses
|
journal | October 2018 |
Similar Records
Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease
Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase